Pfizer Ends Sangamo Alliance With Gene Therapy for Hemophilia on Cusp of FDA Filing
Posted:
Pfizer is walking away from partner Sangamo Therapeutics ahead of expected regulatory submissions for the hemophilia A gene therapy they co-developed. Cash-strapped Sangamo said it is now looking for a new partner for the program.
Read the full article in the latest MedCity News blog post here.
#Healthcare leaders, are you balancing #Interoperability & #DataPrivacy?
Direct EHR access offers benefits but also risks like breaches & revenue loss. Learn safeguards for secure data sharing.
Read more here.
Social care aims to improve the lives of people who need help in their daily living.
Join NIHR webinar to explore how research could improve care for: People experiencing homelessness, People with learning disabilities, People living with dementia.
Secure your…
Attendees
Sponsors and Exhibitors
Webinars
Contact us